SCI
BIIB icon

Stableford Capital II’s Biogen BIIB Stock Holding History

Stableford Capital II’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.49M Buy
6,912
+8
+0.1% +$1.53K 0.52% 43
2026
Q1 		$1.27M Sell
6,904
-10
-0.1% -$1.84K 0.47% 60
2025
Q4 		$1.22M Buy
+6,914
New +$1.13M 0.44% 65

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stableford Capital II's BIIB Position: Q2 2026 in Review

Stableford Capital II increased its Biogen (BIIB) stake by 0.12% in Q2 2026, buying an estimated $1.53K and bringing the position to 6,912 shares worth $1.49M. The position accounts for 0.52% of the portfolio, ranked #43.

Stableford Capital II first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Stableford Capital II held 6,912 shares of Biogen worth $1.49M as of Q2 2026.
  • Stableford Capital II bought 8 Biogen shares in Q2 2026, an estimated $1.53K.
  • Biogen made up 0.52% of Stableford Capital II's portfolio in Q2 2026, its #43 holding.
  • Stableford Capital II first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Stableford Capital II's 13F filing for Q2 2026, filed 6 Jul 2026.